Sanara Medtech Inc (SMTI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sanara Medtech Inc Stock (SMTI) Company Profile

Sanara Medtech Inc

Healthcare (1087)

817-529-2300

1200 SUMMIT AVE, FORT WORTH

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SMTI's Discussions on Twitter

Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SMTI Sanara Medtech Inc	35.00	322.04M	103.14M	-5.82M	2.14M	-4.3526
ISRG Intuitive Surgical Inc	352.60	123.70B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	180.26	48.78B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	69.05	33.41B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	219.41	31.89B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	34.71	30.44B	29.14B	1.07B	1.05B	1.1956

Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Lake Street	Buy
2025-03-26	Bestätigt	H.C. Wainwright	Buy
2024-12-23	Eingeleitet	H.C. Wainwright	Buy
2022-05-20	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-06-30	Eingeleitet	Cantor Fitzgerald	Overweight

Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten

Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)

Sanara Medtech Inc (SMTI)

Sanara Medtech Inc Stock (SMTI) Company Profile

Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN

Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades

Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten

MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail

[DEFM14A] Sanara MedTech Inc. Merger Proxy Statement - Stock Titan

Why (SMTI) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Sanara Medtech Inc (SMTI) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sanara MedTech (SMTI) Holds Steady at $34.57 as Traders Eye Resistance at $36.30ATR Trailing Stop - dars.gov.et

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanar - The National Law Review

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

SMTI | Sanara MedTech Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - Eastern Progress

Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan

Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Update - MarketBeat

Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - MarketBeat

SMTI Q1 2026 Earnings: Positive EPS Surprise Overcomes Expected LossOne-Time Gain Impact - vinanet.vn

Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm

(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada

Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance

Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade

Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView

Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan

MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan

Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria

Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media

Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative

Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times

Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView

Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan

Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan

Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review

Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review

Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review

Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - MarketBeat

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - marketscreener.com

How (SMTI) Movements Inform Risk Allocation Models - Stock Traders Daily

Sanara MedTech (SMTI) Holds Near $33.86 as Support Levels Come into FocusGap Down Bounce Plays - dars.gov.et

SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36 - webull.com

Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com

Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)? - webull.com

MiMedx to Buy Sanara MedTech for $350M - mpo-mag.com

Sanara MedTech (SMTI) agrees to $350 million cash‑and‑stock acquisition by MiMedx - Stock Titan

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK) - GlobeNewswire

MIMEDX To Acquire Sanara MedTech In $350 Million Transaction - Pulse 2.0

Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SMTI